Everence Capital Management’s Pediatrix Medical MD Stock Holding History

Everence Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,840	Closed	-$296K	–	852
2025 Q4	$296K	Hold	13,840	–	–	0.02%	594
2025 Q3	$232K	Hold	13,840	–	–	0.01%	709
2025 Q2	$199K	Hold	13,840	–	–	0.01%	758
2025 Q1	$201K	Hold	13,840	–	–	0.01%	747
2024 Q4	$182K	Buy	13,840 +960	+7%	+$13.3K	0.01%	797
2024 Q3	$149K	Buy	+12,880	New	+$121K	0.01%	731
2023 Q4	–	Sell	-14,540	Closed	-$185	–	778
2023 Q3	$185	Hold	14,540	–	–	0.01%	686
2023 Q2	$193K	Hold	14,540	–	–	0.02%	661
2023 Q1	$217	Hold	14,540	–	–	0.02%	650
2022 Q4	$216	Hold	14,540	–	–	0.02%	673
2022 Q3	$240K	Hold	14,540	–	–	0.02%	593
2022 Q2	$305K	Hold	14,540	–	–	0.03%	514
2022 Q1	$341K	Buy	+14,540	New	+$356K	0.03%	520
2021 Q4	–	Sell	-17,590	Closed	-$500K	–	779
2021 Q3	$500K	Buy	17,590 +8,260	+89%	+$252K	0.04%	403
2021 Q2	$281K	Hold	9,330	–	–	0.02%	582
2021 Q1	$238K	Buy	+9,330	New	+$239K	0.02%	635

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Everence Capital Management's MD Position: Q1 2026 in Review

Everence Capital Management sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 13,840 shares — an estimated $296K sold.

Everence Capital Management first reported a position in MD in Q1 2021 and held it in 16 quarters. The position peaked at $500K in Q3 2021. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Everence Capital Management reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 13,840 Pediatrix Medical shares in Q1 2026, an estimated $296K.
Everence Capital Management first reported a position in Pediatrix Medical in Q1 2021 and held it in 16 quarters.
Everence Capital Management's Pediatrix Medical position peaked at $500K in Q3 2021.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.